TrialBritish journal of clinical pharmacology2015

CYP2B6*6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: impact on adverse effects.

Yibai Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.